Halozyme Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.

About HALO

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.

CEO

Helen I. Torley

CEOHelen I. Torley

Employees

350

Employees350

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

350

Employees350

HALO Key Statistics

Market cap

5.90B

Market cap5.90B

Price-Earnings ratio

12.71

Price-Earnings ratio12.71

Dividend yield

—

Dividend yield—

Average volume

4.68M

Average volume4.68M

High today

$48.19

High today$48.19

Low today

$47.74

Low today$47.74

Open price

$50.24

Open price$50.24

Volume

3.10K

Volume3.10K

52 Week high

$70.51

52 Week high$70.51

52 Week low

$42.01

52 Week low$42.01

HALO News

TipRanks 2d

Halozyme, J&J slide as analyst cuts rating on CMS draft guidance

Shares of Halozyme Therapeutics (HALO) and Jonhson & Johnson (JNJ) are under pressure on Tuesday after Leerink downgraded the stocks to Underperform and Market...

Analyst ratings

44%

of 9 ratings

Buy

44.4%

Hold

44.4%

Sell

11.1%

People also own

Based on the portfolios of people who own HALO. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…